130 related articles for article (PubMed ID: 20948238)
1. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Nakazawa M; Ohguro H; Takeuchi K; Miyagawa Y; Ito T; Metoki T
Ophthalmologica; 2011; 225(2):120-6. PubMed ID: 20948238
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of nilvadipine against progression of the central visual field defect in retinitis pigmentosa: an extended study.
Nakazawa M; Suzuki Y; Ito T; Metoki T; Kudo T; Ohguro H
Biomed Res Int; 2013; 2013():585729. PubMed ID: 24319686
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of influences of ARMS2 polymorphisms on the central visual field in retinitis pigmentosa.
Masahara H; Nakazawa M; Kawamura E; Eguchi S
Ophthalmologica; 2014; 231(1):51-7. PubMed ID: 24217333
[TBL] [Abstract][Full Text] [Related]
5. Wide-field fundus autofluorescence imaging of retinitis pigmentosa.
Oishi A; Ogino K; Makiyama Y; Nakagawa S; Kurimoto M; Yoshimura N
Ophthalmology; 2013 Sep; 120(9):1827-34. PubMed ID: 23631947
[TBL] [Abstract][Full Text] [Related]
6. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.
Pasantes-Morales H; Quiroz H; Quesada O
Metab Brain Dis; 2002 Sep; 17(3):183-97. PubMed ID: 12322788
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Brockhurst RJ; Hayes KC; Johnson EJ; Anderson EJ; Johnson CA; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2010 Apr; 128(4):403-11. PubMed ID: 20385935
[TBL] [Abstract][Full Text] [Related]
8. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of visual field changes determined by Humphrey Field Analyzer 10-2 in patients with Retinitis Pigmentosa.
Sayo A; Ueno S; Kominami T; Nishida K; Inooka D; Nakanishi A; Yasuda S; Okado S; Takahashi K; Matsui S; Terasaki H
Sci Rep; 2017 Nov; 7(1):16383. PubMed ID: 29180701
[TBL] [Abstract][Full Text] [Related]
10. Correlation between macular blood flow and central visual sensitivity in retinitis pigmentosa.
Murakami Y; Ikeda Y; Akiyama M; Fujiwara K; Yoshida N; Nakatake S; Notomi S; Nabeshima T; Hisatomi T; Enaida H; Ishibashi T
Acta Ophthalmol; 2015 Dec; 93(8):e644-8. PubMed ID: 25688697
[TBL] [Abstract][Full Text] [Related]
11. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts.
Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N;
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
[TBL] [Abstract][Full Text] [Related]
13. Natural history of open-angle glaucoma.
Heijl A; Bengtsson B; Hyman L; Leske MC;
Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
[TBL] [Abstract][Full Text] [Related]
14. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma.
Hirooka K; Baba T; Fujimura T; Shiraga F
Am J Ophthalmol; 2006 Sep; 142(3):523-5. PubMed ID: 16935614
[TBL] [Abstract][Full Text] [Related]
15. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].
Bahrami H; Melia M; Dagnelie G
BMC Ophthalmol; 2006 Jun; 6():23. PubMed ID: 16759390
[TBL] [Abstract][Full Text] [Related]
16. Rates of change in the visual field and optic disc in patients with distinct patterns of glaucomatous optic disc damage.
Reis AS; Artes PH; Belliveau AC; Leblanc RP; Shuba LM; Chauhan BC; Nicolela MT
Ophthalmology; 2012 Feb; 119(2):294-303. PubMed ID: 22133797
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
Nagy D; Schönfisch B; Zrenner E; Jägle H
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
[TBL] [Abstract][Full Text] [Related]
18. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
[TBL] [Abstract][Full Text] [Related]
19. Relationship between aqueous flare and visual function in retinitis pigmentosa.
Murakami Y; Yoshida N; Ikeda Y; Nakatake S; Fujiwara K; Notomi S; Nabeshima T; Nakao S; Hisatomi T; Enaida H; Ishibashi T
Am J Ophthalmol; 2015 May; 159(5):958-63.e1. PubMed ID: 25677184
[TBL] [Abstract][Full Text] [Related]
20. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
